Effects of Flumazenil on Recovery After Total Intravenous Anesthesia With Remimazolam
Recruiting
N/A
Interventional Study
Flumazenil Adverse Reaction
Remimazolam
Hip Joint
Elderly Patients
At a Glance
- Age
- 65 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 24 (estimated)
- Sponsor
- Pusan National University Yangsan Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Remimazolam is a medication that has the advantage of a short half-life and reversibility with flumazenil. In clinical situations, the use of flumazenil for the reversal of sedation is common, but there is no precise indication for its administration. In this study, we aim to investigate the necessity of routine flumazenil use after administering remimazolam for intravenous anesthesia.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients over 65 years old scheduled for hip joint surgery
Exclusion Criteria:
* Patients with impaired consciousness or delirium before surgery
* Patients who are hemodynamically unstable before surgery
* Patients with a history of neurological or neuromuscular disorders or…
Contacts